+关注
FlexK
暂无个人介绍
IP属地：未知
6
关注
0
粉丝
0
主题
0
勋章
主贴
热门
FlexK
2021-03-15
NIO go
Better Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote>
FlexK
2021-03-11
👍👍👍
抱歉，原内容已删除
FlexK
2021-05-04
Dropping down trend
After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote>
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575445316557349","uuid":"3575445316557349","gmtCreate":1612351620583,"gmtModify":1615429049906,"name":"FlexK","pinyin":"flexk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.23","exceedPercentage":"60.77%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.23","exceedPercentage":"60.42%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":106493859,"gmtCreate":1620137561771,"gmtModify":1634207536259,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"Dropping down trend","listText":"Dropping down trend","text":"Dropping down trend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/106493859","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://www.laohu8.com/m/news/1157490418?lang=zh_CN&edition=full","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p><p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><blockquote><p style=\"text-align:left;\">（5月4日）继昨日飙升近24%后，OCGN在盘前交易中下跌4%。</p></blockquote></p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><blockquote>本公司之股份<b>奥库根</b>（纳斯达克：OCGN）周一飙升23.8%，此前这家生物技术公司发布了Covaxin研究的有希望的数据，该公司希望将Covaxin引入美国市场。</blockquote></p><p><b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p><blockquote>印度医学研究委员会（ICMR）-国家病毒学研究所的研究人员认为，科瓦克辛可以预防多种冠状病毒株。科瓦克辛似乎对来自巴西的一种名为B.1.128.2的变种有效。此前的一项研究表明，科瓦克辛还可以预防来自英国和印度的变种。</blockquote></p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><blockquote>Ocugen联合创始人兼首席执行官Shankar Musunuri博士在一份新闻稿中表示：“科瓦克辛在迄今为止进行的所有研究中继续显示出强劲的结果。”“我们仍然相信，这种疫苗是我们国家武器库中抗击这一流行病的重要工具。”</blockquote></p><p><b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p><p><blockquote>Musunuri表示，Ocugen向美国提交了一份全面的药物主文件。美国食品药品监督管理局（FDA）。该公司还在准备紧急使用授权的申请。Ocugen与其药物开发合作伙伴、总部位于印度的Bharat Biotech达成的协议规定，如果获得监管授权，该公司将获得在美国销售科瓦克辛利润的45%份额。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-05-04 17:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><blockquote><p style=\"text-align:left;\">（5月4日）继昨日飙升近24%后，OCGN在盘前交易中下跌4%。</p></blockquote></p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><blockquote>本公司之股份<b>奥库根</b>（纳斯达克：OCGN）周一飙升23.8%，此前这家生物技术公司发布了Covaxin研究的有希望的数据，该公司希望将Covaxin引入美国市场。</blockquote></p><p><b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p><blockquote>印度医学研究委员会（ICMR）-国家病毒学研究所的研究人员认为，科瓦克辛可以预防多种冠状病毒株。科瓦克辛似乎对来自巴西的一种名为B.1.128.2的变种有效。此前的一项研究表明，科瓦克辛还可以预防来自英国和印度的变种。</blockquote></p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><blockquote>Ocugen联合创始人兼首席执行官Shankar Musunuri博士在一份新闻稿中表示：“科瓦克辛在迄今为止进行的所有研究中继续显示出强劲的结果。”“我们仍然相信，这种疫苗是我们国家武器库中抗击这一流行病的重要工具。”</blockquote></p><p><b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p><p><blockquote>Musunuri表示，Ocugen向美国提交了一份全面的药物主文件。美国食品药品监督管理局（FDA）。该公司还在准备紧急使用授权的申请。Ocugen与其药物开发合作伙伴、总部位于印度的Bharat Biotech达成的协议规定，如果获得监管授权，该公司将获得在美国销售科瓦克辛利润的45%份额。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322132524,"gmtCreate":1615781774768,"gmtModify":1703492859141,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"NIO go","listText":"NIO go","text":"NIO go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/322132524","repostId":"1161179297","repostType":4,"repost":{"id":"1161179297","kind":"news","pubTimestamp":1615771321,"share":"https://www.laohu8.com/m/news/1161179297?lang=zh_CN&edition=full","pubTime":"2021-03-15 09:22","market":"us","language":"en","title":"Better Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161179297","media":"Motley Fool","summary":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.Stocks of electric-vehicle makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach","content":"<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p><p><blockquote>即使在股价低迷之后，这两家中国电动汽车制造商的估值也很高。</blockquote></p><p> Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p><p><blockquote>电动汽车(EV)制造商的股票在2020年加速上涨。众所周知，中国电动汽车股票是最受欢迎的股票之一，因为这个全球最大的汽车市场继续向交通领域的电气化迈进。</blockquote></p><p> EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p><p><blockquote>2020年，中国电动汽车销量超过100万辆，政府希望到2025年将这一数字增长到500万辆。据研究机构BloombergNEF称，到2030年，这一数字可能达到1000万，到2040年接近2000万。两家希望利用这一扩张的电动汽车制造商是<b>蔚来</b>（纽约证券交易所代码：蔚来）和<b>小鹏</b>（纽约证券交易所代码：XPEV）。投资者可能想知道哪一个更好，尤其是在该行业股价出现调整之后。</blockquote></p><p> <b>The right market</b></p><p><blockquote><b>合适的市场</b></blockquote></p><p> As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p><p><blockquote>如上所述，世界上最大的汽车市场具有巨大的增长潜力。问题是，将会有很多公司寻求资本化。<b>特斯拉</b>（纳斯达克：TSLA）在上海建立第二家制造工厂是有原因的。尽管蔚来和小鹏汽车可能是中国最知名的电动汽车制造商，但它们总共交付了131,000辆纯电动汽车的一半多一点。<b>比亚迪</b>（场外交易代码：比亚迪）2020年售出。</blockquote></p><p> NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p><p><blockquote>蔚来在2020年交付了近44,000辆汽车，而小鹏汽车的销量比2019年增加了一倍多，达到27,041辆。两家公司最近都推出了轿车车型，都希望这些车型能够成为未来销售增长的重要推动力。</blockquote></p><p> XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p><p><blockquote>自2020年初推出以来，小鹏汽车的P7运动型轿车累计交付量已超过20,000辆，超越G3紧凑型SUV成为该公司最受欢迎的汽车。这标志着中国电动汽车初创企业交付20,000辆汽车的最快速度。</blockquote></p><p> NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p><p><blockquote>蔚来今年早些时候推出了新款ET7豪华轿车。ET7将于明年初上市，具有一些复杂的功能。时尚的外观包括自动驾驶传感器、“水晶般的心跳”尾灯、全玻璃车顶和数字进入系统，该系统可以延伸齐平把手，并在驾驶员靠近时自动释放车门的“电子锁”。</blockquote></p><p> <b>Priced for perfection</b></p><p><blockquote><b>完美定价</b></blockquote></p><p> The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p><p><blockquote>强劲的销售增长以及中国电动汽车的巨大潜力已经让投资者涌入这些股票。但在蔚来和小鹏汽车的股价去年飙升后，这些股票分别较2021年1月的高点下跌了27%和38%，现在是看看哪一个可能更好买入的好时机。</blockquote></p><p> Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p><p><blockquote>两家公司都尚未盈利，因此衡量估值的一种方法是使用销售额而不是收益。市销率（P/S）都非常高，但销售额预计将快速增长，这是比较两家公司的相关指标。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的蔚来市值数据</span></p></blockquote></p><p> Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p><p><blockquote>尽管蔚来的市值较高，但以市盈率衡量，它的成本低于小鹏汽车。蔚来还通过其电池更换计划对市场采取了独特的方法，允许客户通过更快的电池更换来“充电”。该公司表示，其自动电池交换站只需三分钟即可更换充满电的电池。</blockquote></p><p> <b>Looking ahead</b></p><p><blockquote><b>展望未来</b></blockquote></p><p> NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p><p><blockquote>蔚来凭借ET7进军豪华轿车领域可能有助于将该公司推向一个新的水平。2020年毛利率、毛利润和经营现金流均为正，表明盈利之路在望。</blockquote></p><p> Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p><p><blockquote>两家公司都希望有足够的资本来资助计划的增长工作。截至2020年12月31日，蔚来资产负债表上的现金和现金等价物、限制性现金和短期投资为65亿美元，小鹏汽车约为54亿美元。两家公司可以通过在香港证券交易所上市来筹集更多资金，据报道，两家公司都在考虑上市。</blockquote></p><p> For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p><p><blockquote>对于只想选择一家公司来参与中国电动汽车增长的投资者来说，蔚来似乎是这两家公司中更好的选择。任何投资仍然属于投资组合的投机部分，有可能出现很大的波动。但对于那些能够承受这一点并进行适当投资的人来说，最近股价的下跌使蔚来目前比小鹏汽车更值得买入。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-15 09:22</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p><p><blockquote>即使在股价低迷之后，这两家中国电动汽车制造商的估值也很高。</blockquote></p><p> Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p><p><blockquote>电动汽车(EV)制造商的股票在2020年加速上涨。众所周知，中国电动汽车股票是最受欢迎的股票之一，因为这个全球最大的汽车市场继续向交通领域的电气化迈进。</blockquote></p><p> EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p><p><blockquote>2020年，中国电动汽车销量超过100万辆，政府希望到2025年将这一数字增长到500万辆。据研究机构BloombergNEF称，到2030年，这一数字可能达到1000万，到2040年接近2000万。两家希望利用这一扩张的电动汽车制造商是<b>蔚来</b>（纽约证券交易所代码：蔚来）和<b>小鹏</b>（纽约证券交易所代码：XPEV）。投资者可能想知道哪一个更好，尤其是在该行业股价出现调整之后。</blockquote></p><p> <b>The right market</b></p><p><blockquote><b>合适的市场</b></blockquote></p><p> As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p><p><blockquote>如上所述，世界上最大的汽车市场具有巨大的增长潜力。问题是，将会有很多公司寻求资本化。<b>特斯拉</b>（纳斯达克：TSLA）在上海建立第二家制造工厂是有原因的。尽管蔚来和小鹏汽车可能是中国最知名的电动汽车制造商，但它们总共交付了131,000辆纯电动汽车的一半多一点。<b>比亚迪</b>（场外交易代码：比亚迪）2020年售出。</blockquote></p><p> NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p><p><blockquote>蔚来在2020年交付了近44,000辆汽车，而小鹏汽车的销量比2019年增加了一倍多，达到27,041辆。两家公司最近都推出了轿车车型，都希望这些车型能够成为未来销售增长的重要推动力。</blockquote></p><p> XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p><p><blockquote>自2020年初推出以来，小鹏汽车的P7运动型轿车累计交付量已超过20,000辆，超越G3紧凑型SUV成为该公司最受欢迎的汽车。这标志着中国电动汽车初创企业交付20,000辆汽车的最快速度。</blockquote></p><p> NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p><p><blockquote>蔚来今年早些时候推出了新款ET7豪华轿车。ET7将于明年初上市，具有一些复杂的功能。时尚的外观包括自动驾驶传感器、“水晶般的心跳”尾灯、全玻璃车顶和数字进入系统，该系统可以延伸齐平把手，并在驾驶员靠近时自动释放车门的“电子锁”。</blockquote></p><p> <b>Priced for perfection</b></p><p><blockquote><b>完美定价</b></blockquote></p><p> The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p><p><blockquote>强劲的销售增长以及中国电动汽车的巨大潜力已经让投资者涌入这些股票。但在蔚来和小鹏汽车的股价去年飙升后，这些股票分别较2021年1月的高点下跌了27%和38%，现在是看看哪一个可能更好买入的好时机。</blockquote></p><p> Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p><p><blockquote>两家公司都尚未盈利，因此衡量估值的一种方法是使用销售额而不是收益。市销率（P/S）都非常高，但销售额预计将快速增长，这是比较两家公司的相关指标。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的蔚来市值数据</span></p></blockquote></p><p> Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p><p><blockquote>尽管蔚来的市值较高，但以市盈率衡量，它的成本低于小鹏汽车。蔚来还通过其电池更换计划对市场采取了独特的方法，允许客户通过更快的电池更换来“充电”。该公司表示，其自动电池交换站只需三分钟即可更换充满电的电池。</blockquote></p><p> <b>Looking ahead</b></p><p><blockquote><b>展望未来</b></blockquote></p><p> NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p><p><blockquote>蔚来凭借ET7进军豪华轿车领域可能有助于将该公司推向一个新的水平。2020年毛利率、毛利润和经营现金流均为正，表明盈利之路在望。</blockquote></p><p> Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p><p><blockquote>两家公司都希望有足够的资本来资助计划的增长工作。截至2020年12月31日，蔚来资产负债表上的现金和现金等价物、限制性现金和短期投资为65亿美元，小鹏汽车约为54亿美元。两家公司可以通过在香港证券交易所上市来筹集更多资金，据报道，两家公司都在考虑上市。</blockquote></p><p> For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p><p><blockquote>对于只想选择一家公司来参与中国电动汽车增长的投资者来说，蔚来似乎是这两家公司中更好的选择。任何投资仍然属于投资组合的投机部分，有可能出现很大的波动。但对于那些能够承受这一点并进行适当投资的人来说，最近股价的下跌使蔚来目前比小鹏汽车更值得买入。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","XPEV":"小鹏汽车"},"source_url":"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161179297","content_text":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.\nEV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are NIO (NYSE:NIO) and XPeng (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.\nThe right market\nAs noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.Tesla (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that BYD (OTC:BYDDY) sold in 2020.\nNIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.\nXPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.\nNIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.\nPriced for perfection\nThe strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.\nNeither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.\nNIO MARKET CAP DATA BY YCHARTS\nThough NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.\nLooking ahead\nNIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.\nBoth companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.\nFor investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.","news_type":1,"symbols_score_info":{"NIO":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":1627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321707278,"gmtCreate":1615468165494,"gmtModify":1703489458782,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"👍👍👍","listText":"👍👍👍","text":"👍👍👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321707278","repostId":"1195977229","repostType":4,"isVote":1,"tweetType":1,"viewCount":2328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":322132524,"gmtCreate":1615781774768,"gmtModify":1703492859141,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"NIO go","listText":"NIO go","text":"NIO go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/322132524","repostId":"1161179297","repostType":4,"repost":{"id":"1161179297","kind":"news","pubTimestamp":1615771321,"share":"https://www.laohu8.com/m/news/1161179297?lang=zh_CN&edition=full","pubTime":"2021-03-15 09:22","market":"us","language":"en","title":"Better Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161179297","media":"Motley Fool","summary":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.Stocks of electric-vehicle makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach","content":"<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p><p><blockquote>即使在股价低迷之后，这两家中国电动汽车制造商的估值也很高。</blockquote></p><p> Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p><p><blockquote>电动汽车(EV)制造商的股票在2020年加速上涨。众所周知，中国电动汽车股票是最受欢迎的股票之一，因为这个全球最大的汽车市场继续向交通领域的电气化迈进。</blockquote></p><p> EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p><p><blockquote>2020年，中国电动汽车销量超过100万辆，政府希望到2025年将这一数字增长到500万辆。据研究机构BloombergNEF称，到2030年，这一数字可能达到1000万，到2040年接近2000万。两家希望利用这一扩张的电动汽车制造商是<b>蔚来</b>（纽约证券交易所代码：蔚来）和<b>小鹏</b>（纽约证券交易所代码：XPEV）。投资者可能想知道哪一个更好，尤其是在该行业股价出现调整之后。</blockquote></p><p> <b>The right market</b></p><p><blockquote><b>合适的市场</b></blockquote></p><p> As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p><p><blockquote>如上所述，世界上最大的汽车市场具有巨大的增长潜力。问题是，将会有很多公司寻求资本化。<b>特斯拉</b>（纳斯达克：TSLA）在上海建立第二家制造工厂是有原因的。尽管蔚来和小鹏汽车可能是中国最知名的电动汽车制造商，但它们总共交付了131,000辆纯电动汽车的一半多一点。<b>比亚迪</b>（场外交易代码：比亚迪）2020年售出。</blockquote></p><p> NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p><p><blockquote>蔚来在2020年交付了近44,000辆汽车，而小鹏汽车的销量比2019年增加了一倍多，达到27,041辆。两家公司最近都推出了轿车车型，都希望这些车型能够成为未来销售增长的重要推动力。</blockquote></p><p> XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p><p><blockquote>自2020年初推出以来，小鹏汽车的P7运动型轿车累计交付量已超过20,000辆，超越G3紧凑型SUV成为该公司最受欢迎的汽车。这标志着中国电动汽车初创企业交付20,000辆汽车的最快速度。</blockquote></p><p> NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p><p><blockquote>蔚来今年早些时候推出了新款ET7豪华轿车。ET7将于明年初上市，具有一些复杂的功能。时尚的外观包括自动驾驶传感器、“水晶般的心跳”尾灯、全玻璃车顶和数字进入系统，该系统可以延伸齐平把手，并在驾驶员靠近时自动释放车门的“电子锁”。</blockquote></p><p> <b>Priced for perfection</b></p><p><blockquote><b>完美定价</b></blockquote></p><p> The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p><p><blockquote>强劲的销售增长以及中国电动汽车的巨大潜力已经让投资者涌入这些股票。但在蔚来和小鹏汽车的股价去年飙升后，这些股票分别较2021年1月的高点下跌了27%和38%，现在是看看哪一个可能更好买入的好时机。</blockquote></p><p> Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p><p><blockquote>两家公司都尚未盈利，因此衡量估值的一种方法是使用销售额而不是收益。市销率（P/S）都非常高，但销售额预计将快速增长，这是比较两家公司的相关指标。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的蔚来市值数据</span></p></blockquote></p><p> Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p><p><blockquote>尽管蔚来的市值较高，但以市盈率衡量，它的成本低于小鹏汽车。蔚来还通过其电池更换计划对市场采取了独特的方法，允许客户通过更快的电池更换来“充电”。该公司表示，其自动电池交换站只需三分钟即可更换充满电的电池。</blockquote></p><p> <b>Looking ahead</b></p><p><blockquote><b>展望未来</b></blockquote></p><p> NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p><p><blockquote>蔚来凭借ET7进军豪华轿车领域可能有助于将该公司推向一个新的水平。2020年毛利率、毛利润和经营现金流均为正，表明盈利之路在望。</blockquote></p><p> Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p><p><blockquote>两家公司都希望有足够的资本来资助计划的增长工作。截至2020年12月31日，蔚来资产负债表上的现金和现金等价物、限制性现金和短期投资为65亿美元，小鹏汽车约为54亿美元。两家公司可以通过在香港证券交易所上市来筹集更多资金，据报道，两家公司都在考虑上市。</blockquote></p><p> For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p><p><blockquote>对于只想选择一家公司来参与中国电动汽车增长的投资者来说，蔚来似乎是这两家公司中更好的选择。任何投资仍然属于投资组合的投机部分，有可能出现很大的波动。但对于那些能够承受这一点并进行适当投资的人来说，最近股价的下跌使蔚来目前比小鹏汽车更值得买入。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: NIO vs. XPeng Motors<blockquote>更值得购买：蔚来与小鹏汽车</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-15 09:22</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.</p><p><blockquote>即使在股价低迷之后，这两家中国电动汽车制造商的估值也很高。</blockquote></p><p> Stocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.</p><p><blockquote>电动汽车(EV)制造商的股票在2020年加速上涨。众所周知，中国电动汽车股票是最受欢迎的股票之一，因为这个全球最大的汽车市场继续向交通领域的电气化迈进。</blockquote></p><p> EV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are <b>NIO</b> (NYSE:NIO) and <b>XPeng</b> (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.</p><p><blockquote>2020年，中国电动汽车销量超过100万辆，政府希望到2025年将这一数字增长到500万辆。据研究机构BloombergNEF称，到2030年，这一数字可能达到1000万，到2040年接近2000万。两家希望利用这一扩张的电动汽车制造商是<b>蔚来</b>（纽约证券交易所代码：蔚来）和<b>小鹏</b>（纽约证券交易所代码：XPEV）。投资者可能想知道哪一个更好，尤其是在该行业股价出现调整之后。</blockquote></p><p> <b>The right market</b></p><p><blockquote><b>合适的市场</b></blockquote></p><p> As noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.<b>Tesla</b> (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that <b>BYD</b> (OTC:BYDDY) sold in 2020.</p><p><blockquote>如上所述，世界上最大的汽车市场具有巨大的增长潜力。问题是，将会有很多公司寻求资本化。<b>特斯拉</b>（纳斯达克：TSLA）在上海建立第二家制造工厂是有原因的。尽管蔚来和小鹏汽车可能是中国最知名的电动汽车制造商，但它们总共交付了131,000辆纯电动汽车的一半多一点。<b>比亚迪</b>（场外交易代码：比亚迪）2020年售出。</blockquote></p><p> NIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.</p><p><blockquote>蔚来在2020年交付了近44,000辆汽车，而小鹏汽车的销量比2019年增加了一倍多，达到27,041辆。两家公司最近都推出了轿车车型，都希望这些车型能够成为未来销售增长的重要推动力。</blockquote></p><p> XPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.</p><p><blockquote>自2020年初推出以来，小鹏汽车的P7运动型轿车累计交付量已超过20,000辆，超越G3紧凑型SUV成为该公司最受欢迎的汽车。这标志着中国电动汽车初创企业交付20,000辆汽车的最快速度。</blockquote></p><p> NIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.</p><p><blockquote>蔚来今年早些时候推出了新款ET7豪华轿车。ET7将于明年初上市，具有一些复杂的功能。时尚的外观包括自动驾驶传感器、“水晶般的心跳”尾灯、全玻璃车顶和数字进入系统，该系统可以延伸齐平把手，并在驾驶员靠近时自动释放车门的“电子锁”。</blockquote></p><p> <b>Priced for perfection</b></p><p><blockquote><b>完美定价</b></blockquote></p><p> The strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.</p><p><blockquote>强劲的销售增长以及中国电动汽车的巨大潜力已经让投资者涌入这些股票。但在蔚来和小鹏汽车的股价去年飙升后，这些股票分别较2021年1月的高点下跌了27%和38%，现在是看看哪一个可能更好买入的好时机。</blockquote></p><p> Neither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.</p><p><blockquote>两家公司都尚未盈利，因此衡量估值的一种方法是使用销售额而不是收益。市销率（P/S）都非常高，但销售额预计将快速增长，这是比较两家公司的相关指标。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf721bd77e4fa0e2530b3d2f86034920\" tg-width=\"720\" tg-height=\"483\"><span>NIO MARKET CAP DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的蔚来市值数据</span></p></blockquote></p><p> Though NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.</p><p><blockquote>尽管蔚来的市值较高，但以市盈率衡量，它的成本低于小鹏汽车。蔚来还通过其电池更换计划对市场采取了独特的方法，允许客户通过更快的电池更换来“充电”。该公司表示，其自动电池交换站只需三分钟即可更换充满电的电池。</blockquote></p><p> <b>Looking ahead</b></p><p><blockquote><b>展望未来</b></blockquote></p><p> NIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.</p><p><blockquote>蔚来凭借ET7进军豪华轿车领域可能有助于将该公司推向一个新的水平。2020年毛利率、毛利润和经营现金流均为正，表明盈利之路在望。</blockquote></p><p> Both companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.</p><p><blockquote>两家公司都希望有足够的资本来资助计划的增长工作。截至2020年12月31日，蔚来资产负债表上的现金和现金等价物、限制性现金和短期投资为65亿美元，小鹏汽车约为54亿美元。两家公司可以通过在香港证券交易所上市来筹集更多资金，据报道，两家公司都在考虑上市。</blockquote></p><p> For investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.</p><p><blockquote>对于只想选择一家公司来参与中国电动汽车增长的投资者来说，蔚来似乎是这两家公司中更好的选择。任何投资仍然属于投资组合的投机部分，有可能出现很大的波动。但对于那些能够承受这一点并进行适当投资的人来说，最近股价的下跌使蔚来目前比小鹏汽车更值得买入。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","XPEV":"小鹏汽车"},"source_url":"https://www.fool.com/investing/2021/03/14/better-buy-nio-vs-xpeng-motors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161179297","content_text":"The Chinese electric-vehicle makers both have rich valuations, even after a downturn in share prices.\nStocks of electric-vehicle (EV) makers accelerated in 2020. And it's no secret that Chinese EV stocks were some of the most popular, as the largest automotive market in the world continues to move toward electrification in its transportation sector.\nEV sales in China surpassed 1 million in 2020, and the government hopes to grow that to 5 million by 2025. It could reach 10 million by 2030, and approach 20 million by 2040, according to research organization BloombergNEF. Two electric automakers looking to capitalize on that expansion are NIO (NYSE:NIO) and XPeng (NYSE:XPEV). Investors may be wondering which is the better buy, particularly after a correction has hit share prices in the sector.\nThe right market\nAs noted above, the largest automotive market in the world has much potential forEV growth. The problem is, there will be plenty of companies seeking to capitalize.Tesla (NASDAQ:TSLA) built its second manufacturing plant in Shanghai for a reason. And though they're maybe the most well-known Chinese EV makers, NIO and XPeng combined delivered only slightly more than half the 131,000 battery-electric vehicles that BYD (OTC:BYDDY) sold in 2020.\nNIO reached almost 44,000 vehicles delivered in 2020, while XPeng more than doubled its volume versus 2019 to 27,041. Both companies have recently introduced sedan models that each hopes will be significant drivers of future sales growth.\nXPeng's P7 sports sedan has surpassed a total of 20,000 cumulative deliveries since its launch in early 2020, as it moves ahead of the G3 compact SUV as the company's most popular vehicle. That marked the fastest pace to 20,000 vehicle deliveries of any Chinese EV start-up.\nNIO introduced its new ET7 luxury sedan earlier this year. The ET7 will be available early next year, and has some intricate features. The sleek exterior includes autonomous driving sensors, a \"crystal-like heartbeat\" tail light, all-glass roof, and a digital entry system that extends the flush handle and automatically releases the door's \"e-latch\" as the driver approaches.\nPriced for perfection\nThe strong sales growth along with massive potential for Chinese EVs had investors already piling into these stocks. But after shares of both NIO and XPeng soared last year, the stocks are off January 2021 highs by 27% and 38% respectively, making now a good time to see which may be the better buy.\nNeither company is profitable yet, so one way to measure valuations is using sales rather than earnings. The price-to-sales ratios (P/S) are both very high, but sales are expected to grow quickly, and it's a relevant metric for comparing the two companies.\nNIO MARKET CAP DATA BY YCHARTS\nThough NIO has the higher market cap, it is less expensive than XPeng as measured by the P/S ratio. NIO also has a unique approach to the market with its battery swap program, which allows customers to \"recharge\" via a faster battery exchange. The company says its automated battery swap stations take only three minutes to produce a fully charged battery replacement.\nLooking ahead\nNIO's push into the luxury sedan segment with its ET7 could help advance the company to the next level. Gross margins, gross profit, and operating cash flow went positive in 2020, indicating the path to profitability is in sight.\nBoth companies look to be adequately capitalized to fund planned growth efforts. As of Dec. 31, 2020, NIO had $6.5 billion in cash and cash equivalents, restricted cash, and short-term investment on its balance sheet, and XPeng had about $5.4 billion. The companies could raise more money by listing on the Hong Kong Stock Exchange, which is reportedly being considered by both.\nFor investors looking to pick just one holding to participate in Chinese EV growth, NIO appears to be the better option of these two companies. Any investment still belongs in the speculative portion of a portfolio, with the potential for much volatility. But for those who can stomach that, and have an appropriate portion invested, the recent drop in shares helps make NIO a better buy than XPeng right now.","news_type":1,"symbols_score_info":{"NIO":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":1627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321707278,"gmtCreate":1615468165494,"gmtModify":1703489458782,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"👍👍👍","listText":"👍👍👍","text":"👍👍👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321707278","repostId":"1195977229","repostType":4,"isVote":1,"tweetType":1,"viewCount":2328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106493859,"gmtCreate":1620137561771,"gmtModify":1634207536259,"author":{"id":"3575445316557349","authorId":"3575445316557349","name":"FlexK","avatar":"https://static.tigerbbs.com/5218345f4899882a5ef1356407aa5eb5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575445316557349","idStr":"3575445316557349"},"themes":[],"htmlText":"Dropping down trend","listText":"Dropping down trend","text":"Dropping down trend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/106493859","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://www.laohu8.com/m/news/1157490418?lang=zh_CN&edition=full","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p><p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><blockquote><p style=\"text-align:left;\">（5月4日）继昨日飙升近24%后，OCGN在盘前交易中下跌4%。</p></blockquote></p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><blockquote>本公司之股份<b>奥库根</b>（纳斯达克：OCGN）周一飙升23.8%，此前这家生物技术公司发布了Covaxin研究的有希望的数据，该公司希望将Covaxin引入美国市场。</blockquote></p><p><b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p><blockquote>印度医学研究委员会（ICMR）-国家病毒学研究所的研究人员认为，科瓦克辛可以预防多种冠状病毒株。科瓦克辛似乎对来自巴西的一种名为B.1.128.2的变种有效。此前的一项研究表明，科瓦克辛还可以预防来自英国和印度的变种。</blockquote></p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><blockquote>Ocugen联合创始人兼首席执行官Shankar Musunuri博士在一份新闻稿中表示：“科瓦克辛在迄今为止进行的所有研究中继续显示出强劲的结果。”“我们仍然相信，这种疫苗是我们国家武器库中抗击这一流行病的重要工具。”</blockquote></p><p><b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p><p><blockquote>Musunuri表示，Ocugen向美国提交了一份全面的药物主文件。美国食品药品监督管理局（FDA）。该公司还在准备紧急使用授权的申请。Ocugen与其药物开发合作伙伴、总部位于印度的Bharat Biotech达成的协议规定，如果获得监管授权，该公司将获得在美国销售科瓦克辛利润的45%份额。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading<blockquote>继昨天飙升近24%后，OCGN在盘前交易中下跌4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-05-04 17:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p style=\"text-align:left;\">(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><blockquote><p style=\"text-align:left;\">（5月4日）继昨日飙升近24%后，OCGN在盘前交易中下跌4%。</p></blockquote></p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p>Shares of <b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><blockquote>本公司之股份<b>奥库根</b>（纳斯达克：OCGN）周一飙升23.8%，此前这家生物技术公司发布了Covaxin研究的有希望的数据，该公司希望将Covaxin引入美国市场。</blockquote></p><p><b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p><blockquote>印度医学研究委员会（ICMR）-国家病毒学研究所的研究人员认为，科瓦克辛可以预防多种冠状病毒株。科瓦克辛似乎对来自巴西的一种名为B.1.128.2的变种有效。此前的一项研究表明，科瓦克辛还可以预防来自英国和印度的变种。</blockquote></p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><blockquote>Ocugen联合创始人兼首席执行官Shankar Musunuri博士在一份新闻稿中表示：“科瓦克辛在迄今为止进行的所有研究中继续显示出强劲的结果。”“我们仍然相信，这种疫苗是我们国家武器库中抗击这一流行病的重要工具。”</blockquote></p><p><b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p><p><blockquote>Musunuri表示，Ocugen向美国提交了一份全面的药物主文件。美国食品药品监督管理局（FDA）。该公司还在准备紧急使用授权的申请。Ocugen与其药物开发合作伙伴、总部位于印度的Bharat Biotech达成的协议规定，如果获得监管授权，该公司将获得在美国销售科瓦克辛利润的45%份额。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
